Is Novo Nordisk A/S (NVO) A Good Stock To Buy Now?

Is NVO a good stock to buy? We came across a bullish thesis on Novo Nordisk A/S on Unfair Advantage’s Substack by AK. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S’s share was trading at $38.52 as of April 23rd. NVO’s trailing and forward P/E were 10.65 and 11.38 respectively according to Yahoo Finance.

I'll Play, Says Jim Cramer About Bristol-Myers (BMY)

Photo by Myriam Zilles on Unsplash

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and...